Zacks Investment Research upgraded shares of Exponent Inc. (NASDAQ:EXPO) from a strong sell rating to a hold rating in a research note published on Tuesday.

According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “

Other equities analysts have also recently issued reports about the company. Avondale Partners began coverage on Exponent in a research report on Thursday, July 7th. They issued a market perform rating and a $60.00 price target for the company. Cantor Fitzgerald began coverage on Exponent in a research report on Friday, August 26th. They issued a buy rating and a $57.00 price target for the company.

Exponent (NASDAQ:EXPO) opened at 49.80 on Tuesday. The company has a market cap of $1.29 billion, a PE ratio of 28.46 and a beta of 0.81. The stock’s 50 day moving average price is $50.45 and its 200 day moving average price is $51.80. Exponent has a 12-month low of $43.05 and a 12-month high of $59.71.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Tuesday, July 19th. The company reported $0.38 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by $0.05. The company earned $77.30 million during the quarter, compared to analysts’ expectations of $80.46 million. Exponent had a net margin of 15.13% and a return on equity of 16.02%. Equities research analysts anticipate that Exponent will post $1.59 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 23rd. Investors of record on Friday, September 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.45%. The ex-dividend date of this dividend is Wednesday, August 31st. Exponent’s payout ratio is 41.62%.

In related news, insider Paul Boehm sold 5,000 shares of the business’s stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $51.42, for a total transaction of $257,100.00. Following the completion of the transaction, the insider now directly owns 29,045 shares in the company, valued at $1,493,493.90. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Paul R. Johnston sold 5,500 shares of the business’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $59.27, for a total value of $325,985.00. Following the transaction, the chief executive officer now owns 58,958 shares of the company’s stock, valued at $3,494,440.66. The disclosure for this sale can be found here. Corporate insiders own 3.50% of the company’s stock.

Institutional investors have recently bought and sold shares of the company. Mason Street Advisors LLC acquired a new position in Exponent during the second quarter valued at approximately $296,000. Schwab Charles Investment Management Inc. raised its stake in shares of Exponent by 1.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 90,038 shares of the company’s stock valued at $5,260,000 after buying an additional 1,482 shares during the period. Legal & General Group Plc raised its stake in shares of Exponent by 54.7% in the second quarter. Legal & General Group Plc now owns 5,658 shares of the company’s stock valued at $323,000 after buying an additional 2,000 shares during the period. Arizona State Retirement System raised its stake in shares of Exponent by 3.1% in the second quarter. Arizona State Retirement System now owns 13,496 shares of the company’s stock valued at $788,000 after buying an additional 400 shares during the period. Finally, Teachers Retirement System of The State of Kentucky raised its stake in shares of Exponent by 3.5% in the second quarter. Teachers Retirement System of The State of Kentucky now owns 41,480 shares of the company’s stock valued at $2,422,000 after buying an additional 1,400 shares during the period. Institutional investors and hedge funds own 91.46% of the company’s stock.

Exponent Company Profile

Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.

5 Day Chart for NASDAQ:EXPO

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.